Please use this identifier to cite or link to this item: http://archive.cmb.ac.lk:8080/xmlui/handle/70130/7608
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMadhushika, K.D.C.-
dc.contributor.authorHapuarachchi, S.D.-
dc.contributor.authorSuresh, T.S.-
dc.contributor.authorPerera, P.K.-
dc.contributor.authorKodithuwakku, N.D.-
dc.contributor.authorDahanayake, J.M.-
dc.contributor.authorArawwawala, L.D.A.M.-
dc.date.accessioned2025-02-11T08:25:36Z-
dc.date.available2025-02-11T08:25:36Z-
dc.date.issued2024-
dc.identifier.issn2659-2029-
dc.identifier.urihttp://archive.cmb.ac.lk:8080/xmlui/handle/70130/7608-
dc.description.abstractBackground: Balabilvashunti decoction (BD) is an ayurvedic polyherbal formulation comprised of three plant ingredients: rhizome of Zingiber officinale, whole plant of Sida alnifolia, and root bark of Aegle marmelos. BD is widely utilized within clinical practice, particularly for addressing geriatric diseases. However, despite its prevalence, patients encounter several limitations when BD is prescribed. These include the substantial time required for decoction preparation, difficulty in finding the correct raw materials due to adulteration and the short shelf-life of the prepared decoction.en_US
dc.language.isoenen_US
dc.publisherUniversity of Ruhunaen_US
dc.subjectAntioxidanten_US
dc.subjectBalabilvashuntien_US
dc.subjectDecoctionen_US
dc.subjectSpray-dryen_US
dc.titleInvestigation of Comparative Bioactivities of Modified Dosage Forms of an Ayurvedic Polyherbal Formulationen_US
dc.typeArticleen_US
Appears in Collections:Department of Ayurveda Pharmacology, Pharmaceutics and Community Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.